120 related articles for article (PubMed ID: 34807805)
21. Magnitude of the Age-Advancement Effect of Comorbidities in Colorectal Cancer Prognosis.
Boakye D; Walter V; Jansen L; Martens UM; Chang-Claude J; Hoffmeister M; Brenner H
J Natl Compr Canc Netw; 2020 Jan; 18(1):59-68. PubMed ID: 31910379
[TBL] [Abstract][Full Text] [Related]
22. Comorbidity and survival of Danish breast cancer patients from 2000-2011: a population-based cohort study.
Ording AG; Cronin-Fenton DP; Jacobsen JB; Nørgaard M; Thomsen RW; Christiansen P; Søgaard M
Clin Epidemiol; 2013; 5(Suppl 1):39-46. PubMed ID: 24227922
[TBL] [Abstract][Full Text] [Related]
23. Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach.
Stewart-Merrill SB; Thompson RH; Boorjian SA; Psutka SP; Lohse CM; Cheville JC; Leibovich BC; Frank I
J Clin Oncol; 2015 Dec; 33(35):4151-7. PubMed ID: 26351352
[TBL] [Abstract][Full Text] [Related]
24. Association of the Charlson comorbidity index with mortality in systemic lupus erythematosus.
Jönsen A; Clarke AE; Joseph L; Belisle P; Bernatsky S; Nived O; Bengtsson AA; Sturfelt G; Pineau CA
Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1233-7. PubMed ID: 21618451
[TBL] [Abstract][Full Text] [Related]
25. The impact of comorbidity on overall survival in elderly nasopharyngeal carcinoma patients: a National Cancer Data Base analysis.
Huang Y; Chen W; Haque W; Verma V; Xing Y; Teh BS; Brian Butler E
Cancer Med; 2018 Apr; 7(4):1093-1101. PubMed ID: 29493889
[TBL] [Abstract][Full Text] [Related]
26. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
27. Simplified cardiovascular index may be the best comorbidity index for clinical use in prediction of mortality for renal cancer patients.
Boynton D; Noyes SL; Murali A; Peabody H; Krumm A; Singh K; Lane BR
Urol Oncol; 2024 Mar; 42(3):72.e1-72.e8. PubMed ID: 38242826
[TBL] [Abstract][Full Text] [Related]
28. Comorbidities and sex differences in causes of death among mantle cell lymphoma patients - A nationwide population-based cohort study.
Glimelius I; Smedby KE; Eloranta S; Jerkeman M; Weibull CE
Br J Haematol; 2020 Apr; 189(1):106-116. PubMed ID: 31721156
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous Cryoablation for Stage 1 Renal Cell Carcinoma: Outcomes from a 10-year Prospective Study and Comparison with Matched Cohorts from the National Cancer Database.
Morkos J; Porosnicu Rodriguez KA; Zhou A; Kolarich AR; Frangakis C; Rodriguez R; Georgiades CS
Radiology; 2020 Aug; 296(2):452-459. PubMed ID: 32515677
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Comorbidity on Survival in Patients With Head and Neck Squamous Cell Carcinoma: A Nationwide Case-Control Study Spanning 35 Years.
Ruud Kjær EK; Jensen JS; Jakobsen KK; Lelkaitis G; Wessel I; von Buchwald C; Grønhøj C
Front Oncol; 2020; 10():617184. PubMed ID: 33680938
[TBL] [Abstract][Full Text] [Related]
31. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.
Tetsche MS; Dethlefsen C; Pedersen L; Sorensen HT; Norgaard M
BMC Cancer; 2008 Jan; 8():31. PubMed ID: 18230177
[TBL] [Abstract][Full Text] [Related]
32. Association between Charlson comorbidity index and survival outcomes in patients with prostate cancer: A meta-analysis.
Cui F; Qiu Y; Xu W; Shan Y; Liu C; Zou C; Fan Y
Heliyon; 2024 Feb; 10(4):e25728. PubMed ID: 38390166
[TBL] [Abstract][Full Text] [Related]
33. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.
Lund L; Borre M; Jacobsen J; Sørensen HT; Nørgaard M
Urology; 2008 Dec; 72(6):1258-62. PubMed ID: 18342917
[TBL] [Abstract][Full Text] [Related]
34. Venous thromboembolism and effect of comorbidity in bladder cancer: A danish nationwide cohort study of 13,809 patients diagnosed between 1995 and 2011.
Ording AG; Nielsen ME; Smith AB; Horváth-Puhó E; Sørensen HT
Urol Oncol; 2016 Jul; 34(7):292.e1-8. PubMed ID: 26971189
[TBL] [Abstract][Full Text] [Related]
35. Comorbidity and the increased mortality after hospitalization for stroke: a population-based cohort study.
Corraini P; Szépligeti SK; Henderson VW; Ording AG; Horváth-Puhó E; Sørensen HT
J Thromb Haemost; 2018 Feb; 16(2):242-252. PubMed ID: 29171148
[TBL] [Abstract][Full Text] [Related]
36. Does comorbidity interact with colorectal cancer to increase mortality? A nationwide population-based cohort study.
Erichsen R; Horváth-Puhó E; Iversen LH; Lash TL; Sørensen HT
Br J Cancer; 2013 Oct; 109(7):2005-13. PubMed ID: 24022185
[TBL] [Abstract][Full Text] [Related]
37. Charlson Comorbidity Index is a predictor of outcomes in incident hemodialysis patients and correlates with phase angle and hospitalization.
Di Iorio B; Cillo N; Cirillo M; De Santo NG
Int J Artif Organs; 2004 Apr; 27(4):330-6. PubMed ID: 15163067
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of indeterminate lung nodules in renal cell carcinoma.
Xu R; Horick N; McGovern FJ; Dahl DM; Feldman AS; Blute ML; Olumi AF; Michaelson MD
Urol Oncol; 2014 Apr; 32(3):355-61. PubMed ID: 24397994
[TBL] [Abstract][Full Text] [Related]
39. Predicting mortality from change-over-time in the Charlson Comorbidity Index: A retrospective cohort study in a data-intensive UK health system.
Fraccaro P; Kontopantelis E; Sperrin M; Peek N; Mallen C; Urban P; Buchan IE; Mamas MA
Medicine (Baltimore); 2016 Oct; 95(43):e4973. PubMed ID: 27787358
[TBL] [Abstract][Full Text] [Related]
40. Renal cell carcinoma in the Canadian Indigenous population.
Wong ECL; Breau RH; Mallick R; Wood L; Pouliot F; Basappa NS; Tanguay S; Soulières D; So A; Heng D; Lavallée LT; Drachenberg D; Kapoor A
Curr Oncol; 2019 Jun; 26(3):e367-e371. PubMed ID: 31285681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
